Navigation Links
Mixed News on Tough-to-Treat Lung Cancer
Date:1/10/2012

By Jenifer Goodwin
HealthDay Reporter

TUESDAY, Jan. 10 (HealthDay News) -- Dutch researchers report disappointing results from an early clinical trial of the drug Nexavar (sorafenib) in fighting a tough-to-treat form of lung cancer.

But, in better news, an experimental drug known as ganetespib showed promise in laboratory and animal experiments.

The results of both studies were to be presented Tuesday at an American Association for Cancer Research/International Association for the Study of Lung Cancer meeting in San Diego.

In recent years, researchers have made some headway in finding treatments to combat lung cancer, which often doesn't respond well to chemotherapy, explained Dr. Len Lichtenfeld, deputy chief medical officer of the American Cancer Society.

Those treatments include drugs such as crizotinib (Xalkori) and erlotinib (Tarceva), which are most effective in tumors that contain certain genetic mutations.

However, those drugs tend to not work well in people with tumors that contain a particular type of mutation in the KRAS gene. KRAS is the most common molecular mutation, present in about 25 percent of people with non-small cell lung cancers such as adenocarcinoma, particularly smokers, said Dr. Paul Bunn, a professor of lung cancer research at the University of Colorado and executive director of the International Association for the Study of Lung Cancer.

"The patients who have this mutation have a somewhat worse prognosis than patients who don't have this mutation, and have worse outcomes with chemotherapy," Bunn said. "Most drugs produce a shrinkage of the tumor in less than 10 percent of KRAS patients."

While a smaller, even earlier trial showed sorafenib might be that drug, the latest findings were not impressive. This larger trial by researchers in the Netherlands involving 57 patients with non-small cell lung cancer who had already failed chemotherapy and who had the KRA
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Scientists Create First Monkeys With Mixed Genomes
2. Panels Rejection of PSA Test Spurs Mixed Reaction From Experts
3. Mixed Results Seen With Off-Label Use of Antipsychotics
4. Bone drug is mixed blessing for breast cancer patients
5. Trials of Type 1 Diabetes Vaccines Bring Mixed Results
6. Models Photos May Spur Mixed Messages About Body Image
7. Americas Health a Mixed Bag: Report
8. Elder law expert: Health care reform act a mixed bag for seniors
9. Antibiotics a Mixed Bag for Kids Ear Infections: Analysis
10. U.S. Report on Kids Health Brings Mixed Results
11. Extending lifespan has mixed effects on learning and memory
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mixed News on Tough-to-Treat Lung Cancer
(Date:8/1/2015)... , ... August 02, 2015 , ... Back packs can ... a school, however, back packs can wreck havoc on a kid's spine. With school ... supplies to and from school. Make sure you are aware of how to help ...
(Date:8/1/2015)... ... ... Tina Wilcoxson, owner of Freeport Maine’s Royal River Natural Foods, was named one ... Federation, the largest retail trade association in the world, for her “advocacy and engagement” ... named as such. According to the NRF’s website, Retail Champions are “Main Street business ...
(Date:8/1/2015)... ... August 01, 2015 , ... BeverlyD, owner and founder of ... making hers the very first small business donation to kick off the campaign for ... thirty years. Her legacy includes a complete line of raw, organic hair care products, ...
(Date:7/31/2015)... New York (PRWEB) , ... July 31, 2015 , ... ... strut their stuff, Super-Sod debuted their new type of sod called Leisure Time(TM) ... trademark application in process. , To commemorate introduction of this new type of sod, ...
(Date:7/31/2015)... ... July 31, 2015 , ... Recently touted ... in predictive health analytics , Jvion continues to disrupt the predictive analytic ... software that targets patient and population level illness to drive prevention and better ...
Breaking Medicine News(10 mins):Health News:Local AlignLife Doctor Donates Time to Check Back Packs 2Health News:Local Retail Advocate Wins National Recognition 2Health News:March4thforWellBeing Foundation Kickoff 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2
... Australia has earmarked $74 million to combat the bird flu ... Howard was to announce the funding in Busan, Korea, where ... forum., ,International agencies, like the World Health Organization (WHO), ... percent would go on a simulation exercise run by APEC ...
... had problems with the placenta during pregnancy are at an ... reports BBC online., ,Placenta is a tube through which ... mother and gets rid of waste products. , ,Doctor ... studied over a million women who were free from cardiovascular ...
... the World Health Organization (WHO) experts, concerted efforts, ... eradication of the five neglected tropical diseases from ... years. , WHO has identified five tropical ... (kala azar), soil transmitted helminths (STH) and yaws ...
... scientists present the first proof that simple exposure to cold weather ... your mother always warned you to wrap up warm to // ... point. , Scientists say they have the first proof that ... , Their study findings will appear in this week’s The ...
... the national nursing shortage by producing more qualified nursing ... Robert W. Woodruff Foundation has awarded // $995,000 to ... support its new doctorate of nursing practice program, the ... ,Thanking the Atlanta-based Woodruff Foundation, a private organization, for ...
... graduate, Leena Bahl Palomo, D.D.S and M.S.D, tracked 60 ... for osteoporosis and who had also visited the Case ... Case's department of Periodontology; and James Liu, chair of ... of Cleveland collaborated with Ms Palomo in the study. ...
Cached Medicine News:Health News:Placenta Problems In Pregnancy Linked To Early Heart Disease 2Health News:Concerted Effort Imperative For Elimination Of Tropical Diseases: WHO 2Health News:Scientist Affirm Mom’s Advice - Keep Yourself Wrapped Up To Avoid Cold 2Health News:Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program 2Health News:Drugs Used In Osteoporosis Can Help Prevent Periodontal Bone Loss 2
(Date:7/30/2015)... PARK, N.J. , July 30, 2015  Unichem ... voluntarily recalling one lot of Hydrochlorothiazide tablets 25 mg ... been initiated as a precautionary measure due to the ... of the product. The risk associated ... Hydrochlorothiazide tablet is the increased probability of experiencing Clopidogrel,s ...
(Date:7/30/2015)... July 30, 2015 PTC Therapeutics, Inc. (NASDAQ: ... reported financial results for the second quarter ending June ... many fronts across the organization.  We are excited to ... dystrophy clinical trial ever conducted with topline results expected ... Chief Executive Officer, PTC Therapeutics, Inc. "Translarna is now ...
(Date:7/30/2015)... , July 30, 2015  Cleveland Clinic President ... 2015 keynote address last month that industry is compelled ... order to gain the efficiencies—and develop the transformational innovations ... Dr. Barsoum,s comments were preceded by Doug Kohrs ... and OMTEC moderator, who stressed that industry must add ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2
... MUNDELEIN, Ill. , July 1 ... and information systems developer, today announces executive changes in ...  John Kershaw, President & CEO, Sysmex America Inc. has ... Secretary; Judy Bosko as Vice President of ...
... SCHAUMBURG, Ill. , July 1 ... today announced that the U.S. Food and Drug Administration ... sodium injection, USP. Heparin is a vital anticoagulant, preventing ... within the blood, routinely used in surgical and dialysis ...
Cached Medicine Technology:Sysmex America Announces Executive Leadership Changes 2FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 2FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 3FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 4
... a centimeter ruler etched into the gel tray ... includes apparatus, connecting cables, three 7x10 cm gel ... three 14-well combs. The Chameleon can accomodate up ... of a maximum of 120 samples with a ...
... of a Separation-Control unit for system control ... gel staining. The optional PhastTransfer Kit quickly ... unit. Electrophoresis is performed on a thermostatic ... 0 to +70 C. Multi-step programming capability ...
... The SEA 2000 apparatus and ready-to-use gels ... for analysis of nucleic acids by submerged ... complete this system, offering full compatibility and ... Besides the SEA 2000 and a unique ...
... SEA 2000 apparatus and ready-to-use gels are ... analysis of nucleic acids by submerged gel ... this system, offering full compatibility and optimal ... the SEA 2000 and a unique staining ...
Medicine Products: